Search
Close
Menu
  • Services
    • Services
      • BioAgilytix Diagnostics
      • Biomarker Menu
      • DMPK Assays
      • Dose Formulation Analysis
      • Large Molecule Bioanalysis
      • Method Development & Validation
      • Pharmacokinetic Analysis And Reports
      • Protein Binding Assays
      • Small Molecule Bioanalysis
      • Specimen Collection Kits
    • Solutions
      • Antibody Drug Conjugates
      • Biosimilars
      • CAR-T Cell Therapy
      • Gene Therapy
      • Immuno-Oncology
      • Modified & Novel Vehicles For Gene Therapy
      • Vaccines
    • Assay Focus
      • Assay Focus
      • Biomarkers
      • Cell-Based Assays
      • Immunogenicity
      • Pharmacokinetics
      • Toxicology Studies
    • Process Management
      • Process Management
      • Agricultural Biotechnology
      • Data Management
      • Industries Served
      • Pharma & Biotech
      • Project Management
      • Sample Management
    • Therapeutic Area Expertise
      • Therapeutic Area Expertise
      • Autoimmune
      • Metabolic
      • Neurology
      • Oncology
      • Virology
  • Technology
    • Our Platforms
      • ELISA
      • MSD-ECL
      • Flow Cytometry
      • Quantitative Real-Time PCR (qPCR)
      • Roche cobas Analyzer
      • Gyrolab
      • Ella
      • LI-COR Odyssey
      • Luminex
      • Biacore
      • ImmunoCAP
      • ELISpot
    • Automation
  • Company
    • About Us
    • Our Capabilities
    • Meet Our Team
    • Industries Served
    • Awards
    • Mission Vision & Values
    • Meet Our Partners
    • The BioAgilytix Way
    • Our Quality Commitment
    • US Headquarters
    • European Headquarters
    • Australian Headquarters
  • Resources
    • Resources
    • Gene & Cell Therapy Center
    • Testimonials
    • Science In 60
    • Our Blog
    • News
    • Case Studies
    • Molecular Moments Podcast
    • FAQ
    • Glossary
    • Articles
    • Podcasts
    • Events
    • Webinars
    • EBooks
    • Infographics
    • Videos
    • Guidance
    • Posters
    • Brochures
    • Papers
  • News & Events
    • News
    • Events
    • Press Kit
  • Careers
    • Careers at BioAgilytix
    • Why BioAgilytix
    • Who Is Our Team
    • How You’ll Benefit
    • What You’ll Enable
SPEAK TO A SCIENTIST
  • Services

    Services

    BioAgilytix Diagnostics

    Biomarker Menu

    DMPK Assays

    Dose Formulation Analysis

    Large Molecule Bioanalysis

    Method Development & Validation

    Our Capabilities

    Pharmacokinetic Analysis & Reports

    Protein Binding Assays

    Small Molecule Bioanalysis

    Specimen Collection Kits

    Solutions

    Antibody Drug Conjugates

    Biosimilars

    CAR-T Cell Therapy

    Gene Therapy

    Immuno-oncology

    Modified & Novel Vehicles for Gene Therapy

    Vaccines

    Assay Focus

    Biomarkers

    Cell-Based Assays

    Immunogenicity

    Pharmacokinetics

    Toxicology Studies

    Process Management

    Agricultural Biotechnology

    Data Management

    Industries Served

    Pharma & Biotech

    Project Management

    Sample Management

    Therapeutic Area Expertise

    Autoimmune

    Metabolic

    Neurology

    Oncology

    Virology

  • Technology

    Our Platforms

    Learn More

    QuantStudio 7 Flex

    (qPCR)

    Luminex Flexmap 3D

    (Luminex)

    Flow Cytometry

    Roche cobas® e411 Analyzer

    (Automated Immunoassays)

    Meso Scale Discovery Sector S600, and QuickPlex SQ 120

    (MSD-Multiplex ECLIA)

    Biacore T200™

    (SPR Biomarker Interactions)

    Phadia 200

    (ImmunoCAP)

    LI-COR Odyssey

    (Western Blot Imager)

    ELISpot reader

    (Immune Cell Cytokine Release)

    Gyrolab™

    (Low Volume Automated ELISA)

    ProteinSimple Ella

    (Multiplex Immunoassay)

    Biotek Synergy NE02 Plate Reader

    (ELISA)

    ddPCR

    Droplet Digital PCR QX200, QX One

    Automation

    Learn More

    Hamilton Microlab® NIMBUS

    Hamilton Microlab® STARlet

    Biomek FXP

    BioTek Microplate Washer

    BioTek Precision™ 2000

    BioTek MultiFlo™ FX

    Perkin Elmer Janus G3 Liquid Handler

    Mantis

    Integra Assist Plus

    Your Partner for Global Bioanalytical Services

    Delivering Premier Science, Deep Experience, and Proven Quality
  • Company

    About Us

    Our Capabilities

    Meet Our Team

    Industries Served

    Awards & Certifications

    Mission Vision & values

    Meet our partners

    The BioAgilytix Way

    Our Quality Commitment

    SAN DIEGO LAB

    34,000 Square Feet

    CRO

    Immunoassay

    Mass Spectrometry

    USA HQ (DURHAM)

    78,685 Square Feet

    Discovery

    Preclinical/clinal

    Manufacturing

    BOSTON LAB

    26,453 Square Feet

    Bioanalytical Services

    Diagnostic Testing

    EUROPEAN HQ (HAMBURG)

    2,777 Square Meters

    Assay Development

    Validation

    Sample Analysis

    Global Disease Studies

    MELBOURNE LAB

    2,777 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    BRISBANE LAB

    1,566 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    Speak to our team

    Available Now

    Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.

  • Resources

    Resources

    Gene & Cell Therapy Center

    Testimonials

    Our Blog

    News

    Case Studies

    Molecular Moments Podcast

    Science in 60

    FAQ

    Glossary

    Resource Center

    Articles

    Podcasts

    Events

    Webinars

    eBooks

    Infographics

    Videos

    Guidance

    Posters

    Brochures

    Papers

    [EPISODE 20] Dr. David Johnson Talks Frosted Flakes, Small Molecules, and Pharmacokinetics!

    May 20, 2022

    On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix

    Share This
    Read More »

    The Use of Cell-Based Assays for Translational Medicine Studies

    July 27, 2022

    Cell-based assays are an important tool in drug development. One of the biggest challenges when developing a drug is mimicking the

    Share This
    Read More »
    Researcher adding samples to a 96 well plate

    Analytical Assays Determine Biosimilar Product Quality

    August 6, 2020

    Summary In an article published by Pharmaceutical Technology Europe, BioAgilytix BioAgilytix supplies its assay expertise to describe the appropriate analytical

    Share This
    Read More »
    Immunogenicity Assessment of Gene Therapy Compounds

    Immunogenicity Assessment of Gene Therapy Compounds

    December 2, 2019

    Summary In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and

    Share This
    Read More »
  • News & Events

    Recent News

    BioAgilytix Achieves Cyber Security Accreditation

    July 21, 2022

    Durham, NC, July 21, 2022 – BioAgilytix Labs, LLC (BioAgilytix) has secured a valuable seal of approval for the safety of

    Share This
    Read More »

    BioAgilytix appoints Nathan Speicher as Chief Financial Officer

    June 27, 2022

    Durham, NC, June 30, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical

    Share This
    Read More »

    Events

    ADA Assessment For Cell Therapies

    Read More »

    ADA Assessment For Cell Therapies

    Read More »

    Press Kit

    Recent News

    The Use of Cell-Based Assays for Translational Medicine Studies

    July 27, 2022

    Cell-based assays are an important tool in drug development. One of the biggest challenges when developing a drug is mimicking the

    Share This
    Read More »

    ADCC and CDC Assay: Validation and Optimization

    July 18, 2022

    ADCC Antibody dependent cellular cytotoxicity (ADCC) is a mechanism in host immune defense where antibodies bind to an antigen on

    Share This
    Read More »

    Origins of CRISPR: How it Came to Be

    July 12, 2022

    Gene editing isn’t a new concept and has been around for decades. In its infancy, gene editing was time-consuming, inaccurate

    Share This
    Read More »

    Events

  • Careers

    Careers

    View Current Career Opportunities

    Why
    BioAgilytix

    Because the best science
    demands the best people.

    Read More

    Who
    is on Our Team

    Meet our Global Colleagues.
    Read More

    How
    You’ll Benefit

    Explore our benefit program
    and company perks.

    Read More

    What
    You’ll Enable

    See how your work will
    change patients’ lives.

    Read More

    Why BioAgilytix?

    Because the best science
    demands the best people.

    Who is on our team?

    Meet our global colleagues.

    How You’ll Benefit?

    Explore our benefit program
    and company perks.

    What You’ll Enable?

    See how your work will
    change patients' lives.

    Who is our team

    Why BioAgilytix

    What You’ll Enable

    How You’ll Benefit

  • Services

    Services

    BioAgilytix Diagnostics

    Biomarker Menu

    DMPK Assays

    Dose Formulation Analysis

    Large Molecule Bioanalysis

    Method Development & Validation

    Our Capabilities

    Pharmacokinetic Analysis & Reports

    Protein Binding Assays

    Small Molecule Bioanalysis

    Specimen Collection Kits

    Solutions

    Antibody Drug Conjugates

    Biosimilars

    CAR-T Cell Therapy

    Gene Therapy

    Immuno-oncology

    Modified & Novel Vehicles for Gene Therapy

    Vaccines

    Assay Focus

    Biomarkers

    Cell-Based Assays

    Immunogenicity

    Pharmacokinetics

    Toxicology Studies

    Process Management

    Agricultural Biotechnology

    Data Management

    Industries Served

    Pharma & Biotech

    Project Management

    Sample Management

    Therapeutic Area Expertise

    Autoimmune

    Metabolic

    Neurology

    Oncology

    Virology

  • Technology

    Our Platforms

    Learn More

    QuantStudio 7 Flex

    (qPCR)

    Luminex Flexmap 3D

    (Luminex)

    Flow Cytometry

    Roche cobas® e411 Analyzer

    (Automated Immunoassays)

    Meso Scale Discovery Sector S600, and QuickPlex SQ 120

    (MSD-Multiplex ECLIA)

    Biacore T200™

    (SPR Biomarker Interactions)

    Phadia 200

    (ImmunoCAP)

    LI-COR Odyssey

    (Western Blot Imager)

    ELISpot reader

    (Immune Cell Cytokine Release)

    Gyrolab™

    (Low Volume Automated ELISA)

    ProteinSimple Ella

    (Multiplex Immunoassay)

    Biotek Synergy NE02 Plate Reader

    (ELISA)

    ddPCR

    Droplet Digital PCR QX200, QX One

    Automation

    Learn More

    Hamilton Microlab® NIMBUS

    Hamilton Microlab® STARlet

    Biomek FXP

    BioTek Microplate Washer

    BioTek Precision™ 2000

    BioTek MultiFlo™ FX

    Perkin Elmer Janus G3 Liquid Handler

    Mantis

    Integra Assist Plus

    Your Partner for Global Bioanalytical Services

    Delivering Premier Science, Deep Experience, and Proven Quality
  • Company

    About Us

    Our Capabilities

    Meet Our Team

    Industries Served

    Awards & Certifications

    Mission Vision & values

    Meet our partners

    The BioAgilytix Way

    Our Quality Commitment

    SAN DIEGO LAB

    34,000 Square Feet

    CRO

    Immunoassay

    Mass Spectrometry

    USA HQ (DURHAM)

    78,685 Square Feet

    Discovery

    Preclinical/clinal

    Manufacturing

    BOSTON LAB

    26,453 Square Feet

    Bioanalytical Services

    Diagnostic Testing

    EUROPEAN HQ (HAMBURG)

    2,777 Square Meters

    Assay Development

    Validation

    Sample Analysis

    Global Disease Studies

    MELBOURNE LAB

    2,777 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    BRISBANE LAB

    1,566 Square Meters

    Pharmacokinetics (PK)
    Pharmacodynamics (PD)
    Virology
    Immunology
    FIH trials & early-phase clinical trials
    Central laboratory services

    Speak to our team

    Available Now

    Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.

  • Resources

    Resources

    Gene & Cell Therapy Center

    Testimonials

    Our Blog

    News

    Case Studies

    Molecular Moments Podcast

    Science in 60

    FAQ

    Glossary

    Resource Center

    Articles

    Podcasts

    Events

    Webinars

    eBooks

    Infographics

    Videos

    Guidance

    Posters

    Brochures

    Papers

    [EPISODE 20] Dr. David Johnson Talks Frosted Flakes, Small Molecules, and Pharmacokinetics!

    May 20, 2022

    On this episode of Molecular Moments, Dr. Jim McNally chats with DMPK Senior Director Dr. David Johnson, Ph.D., from BioAgilytix

    Share This
    Read More »

    The Use of Cell-Based Assays for Translational Medicine Studies

    July 27, 2022

    Cell-based assays are an important tool in drug development. One of the biggest challenges when developing a drug is mimicking the

    Share This
    Read More »
    Researcher adding samples to a 96 well plate

    Analytical Assays Determine Biosimilar Product Quality

    August 6, 2020

    Summary In an article published by Pharmaceutical Technology Europe, BioAgilytix BioAgilytix supplies its assay expertise to describe the appropriate analytical

    Share This
    Read More »
    Immunogenicity Assessment of Gene Therapy Compounds

    Immunogenicity Assessment of Gene Therapy Compounds

    December 2, 2019

    Summary In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and

    Share This
    Read More »
  • News & Events

    Recent News

    BioAgilytix Achieves Cyber Security Accreditation

    July 21, 2022

    Durham, NC, July 21, 2022 – BioAgilytix Labs, LLC (BioAgilytix) has secured a valuable seal of approval for the safety of

    Share This
    Read More »

    BioAgilytix appoints Nathan Speicher as Chief Financial Officer

    June 27, 2022

    Durham, NC, June 30, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical

    Share This
    Read More »

    Events

    ADA Assessment For Cell Therapies

    Read More »

    ADA Assessment For Cell Therapies

    Read More »

    Press Kit

    Recent News

    The Use of Cell-Based Assays for Translational Medicine Studies

    July 27, 2022

    Cell-based assays are an important tool in drug development. One of the biggest challenges when developing a drug is mimicking the

    Share This
    Read More »

    ADCC and CDC Assay: Validation and Optimization

    July 18, 2022

    ADCC Antibody dependent cellular cytotoxicity (ADCC) is a mechanism in host immune defense where antibodies bind to an antigen on

    Share This
    Read More »

    Origins of CRISPR: How it Came to Be

    July 12, 2022

    Gene editing isn’t a new concept and has been around for decades. In its infancy, gene editing was time-consuming, inaccurate

    Share This
    Read More »

    Events

  • Careers

    Careers

    View Current Career Opportunities

    Why
    BioAgilytix

    Because the best science
    demands the best people.

    Read More

    Who
    is on Our Team

    Meet our Global Colleagues.
    Read More

    How
    You’ll Benefit

    Explore our benefit program
    and company perks.

    Read More

    What
    You’ll Enable

    See how your work will
    change patients’ lives.

    Read More

    Why BioAgilytix?

    Because the best science
    demands the best people.

    Who is on our team?

    Meet our global colleagues.

    How You’ll Benefit?

    Explore our benefit program
    and company perks.

    What You’ll Enable?

    See how your work will
    change patients' lives.

    Who is our team

    Why BioAgilytix

    What You’ll Enable

    How You’ll Benefit

Analytical Assays Determine Biosimilar Product Quality

Read more...

Immunogenicity Assessment of Gene Therapy Compounds

Read more...

Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars

Read more...

Clinical relevance of immunogenicity: an interview with Arno Kromminga

Read more...

Exploratory biomarker testing: to qualify or validate the assay?

Read more...

Immunogenicity Considerations for ADCs: A Focus on Neutralizing Antibody Assays

Read more...

Bioanalysis Zone’s “Ask the Experts” Series on Biosimilars

Read more...

Defining Best Practices for Biosimilar Development

Read more...

Cell-Based Assays Keep Biosimilars on Track

Read more...

Interview with Afshin Safavi (Founder & CSO, BioAgilytix) on biomarker analysis in support of preclinical and clinical studies

Read more...

Meeting the Rigorous Demands of Biosimilar Pharmacokinetics

Read more...

How to win client trust as a CRO

Read more...

Running a successful CRO

Read more...

How to set up a successful CRO by surrounding yourself with the right team members

Read more...

Parallelism and Matrix Interference: The Importance of Nomenclature (Part 1)

Read more...

Development and validation of an alpha fetoprotein immunoassay

Read more...

Implementation of a universal analytical method in early-stage development of human antibody therapeutics

Read more...

Validation of a Gyrolab™ assay for quantification of rituximab in human serum

Read more...

Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis

Read more...
CONTACT US
↑
Twitter Linkedin Facebook Instagram Youtube
USA HQ

2300 Englert Dr

Durham, NC, 27713

919-381-6097

Fax 919-381-6099

San Diego Laboratory

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 858-652-4699

Brisbane Laboratory

37 Kent St, Woolloongabba

Queensland, 4102, Australia

Twitter Linkedin Facebook Instagram Youtube
Subscribe to Our Newsletter
USA HQ

2300 Englert Dr

Durham, NC, 27713

919-381-6097

Fax 919-381-6099

San Diego Laboratory

9050 Camino Santa Fe

San Diego, CA 92121

858-652-4600

Fax 617-456-0700

Brisbane Laboratory

37 Kent St,Woolloongabba

Queensland, 4102, Australia

Boston Laboratory

1320 Soldiers Field Road

Boston, MA, 02135

Boston Laboratory

1320 Soldiers Field Road

Boston, MA, 02135

617-456-0700

Fax 617-456-0701

European HQ

Lademannbogen 10

22339 Hamburg Germany

+49 405267790

Melbourne Laboratory

85 Commercial Road, Melbourne

Victoria, 3004, Australia

03 9282 2184

Copyright © 2022 BioAgilytix Labs. All rights reserved.
Terms of Use | Privacy Notice
European HQ

Lademannbogen 10

22339 Hamburg Germany

Melbourne Laboratory

85 Commercial Road, Melbourne

Victoria, 3004, Australia

Subscribe to Our Newsletter

Copyright © 2022 BioAgilytix Labs.

All rights reserved.

Subscribe to Our Newsletter

    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.